An evidence-based approach, like the one used in our sports injury care, prioritizes treatments that are proven to work and, just as importantly, are understood to be safe for long-term health
Although current studies support ferroptosis as a central regulator of selective motor neuron loss in ALS, providing a new mechanistic anchor to link iron accumulation, protein aggregation, and motor neuron degeneration, several fundamental limitations remain
This phase is characterized by the reappearance or worsening of nausea and vomiting accompanied by malaise, jaundice, and central nervous symptoms including confusion, somnolence, and coma

each 10% reduction in homocysteine is associated with 1.45-2.55 reduction in pulse pressure mmHg in patients undergoing hemodialysis (14)(27)(31) Increased urinary excretion of homocysteine in its sulfonated form (36) Omega-3 fatty acids 200-6,000 mg (~98-2,000 mg EPA/490-1,000 mg DHA) per day, for 1-12 months in patients with hyperhomocysteinemia or elevated homocysteine within normal ranges (8)(11)(13)(17)(18)(19)(25)(30)(42)(43) Reduced homocysteine by 1.18-1.58 mol/L on average using wide dose ranges, as shown in meta-analyses (8)(18) Reduced homocysteine by ~2.5-4.0 mol/L in patients with type II diabetes, patients on hemodialysis, or healthy adults using mid-range doses of 2,000-3,600 mg per day for 1-3 months and up to one year (11)(17)(25)(30)(42)(43) Reduced homocysteine by ~1.6 mol/L over 12 months in patients younger than 65 years, previously suffering from myocardial infarction (13) Adjunct therapy with folic acid, vitamin B6, and vitamin B12 improved efficacy (8)(17) Adjunct aerobic exercise and cognitive stimulation may be required for benefit in some populations, including older adults with mild cognitive impairment (19)

No placebo control
Acetil-L-carnitine Acetyl L-Carnitine is used in a more common way for cognitive enhancement, reduction of stress and also helps in fat metabolism